Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study

Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study

Kidney transplant recipients (KTRs) have a suboptimal immune response to COVID-19 vaccination due to the effects of immunosuppression, mostly mycophenolic acid (MPA). This study investigated the benefits of switching from the standard immunosuppressive regimen (tacrolimus (TAC), MPA, and prednisolon...

Full description

Bibliographic Details
Main Authors: Athiphat Banjongjit, Supitchaya Phirom, Jeerath Phannajit, Watsamon Jantarabenjakul, Leilani Paitoonpong, Wonngarm Kittanamongkolchai, Salin Wattanatorn, Wisit Prasithsirikul, Somchai Eiam-Ong, Yingyos Avihingsanon, Pokrath Hansasuta, Jakapat Vanichanan, Natavudh Townamchai
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Vaccines
Subjects:
COVID-19 vaccination
AZD1222
BNT162b2
kidney transplantation
immunosuppression
mycophenolic acid sparing
Online Access:https://www.mdpi.com/2076-393X/10/10/1685

Internet

https://www.mdpi.com/2076-393X/10/10/1685

Similar Items